ARCHIVES

Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | March 20, 2009

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group, Other Cancer Meetings

August 16, 1985

Finasteride Improved Performance Of PSA In Prostate Cancer Prevention Trial

August 25, 2006

An Unusual Week Of Deals In Oncology: Alliances, Sales, and Dramatic Moves

November 13, 1998

In Congress: NCI Defends Role of Advisor In Response To House Inquiry

September 19, 1997

NIH Director Collins Challenged On Capitol Hill Over NCI-Funded Research Linking Tea Party With Tobacco Companies

March 8, 2013

FDA Ceases Exclusion Of Women From Early Drug Studies

May 7, 1993